The UK has left the EU Find out what this means for you

Hide message

Search all content

241 results

241 results sorted by Most viewed

From

Advisory Council on the Misuse of Drugs (ACMD)

  1. Advisory Council on the Misuse of Drugs

    The home of Advisory Council on the Misuse of Drugs on GOV.UK.

  2. Letter from the ACMD to the Home Secretary: GHB, GBL, and related compounds

    Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary in response to the 6 January letter on GHB and GBL.

  3. Call for evidence: barriers to research with controlled drugs

    Letter from the ACMD Barriers to Research working group to collect written evidence from researchers about barriers to legitimate research with controlled drugs.

  4. AMCD inquiry: 'Hidden harm' report on children of drug users

    Report of the findings of the ACMD's inquiry on children of problem drug users in the UK.

  5. Report into homelessness and drug misuse published

    Safe housing key to tackling homeless drug misuse, says ACMD.

  6. The classification of Cannabis under the Misuse of Drugs Act 1971 (2002)

    In October 2001 the Home Secretary asked the Advisory Council on the Misuse of Drugs to review the classification of cannabis preparations in…

  7. Advisory Council on the Misuse of Drugs – About us

    The Advisory Council on the Misuse of Drugs makes recommendations to government on the control of dangerous or otherwise harmful drugs, including classification and scheduling under the Misuse of Drugs Act 1971 and its regul…

  8. ACMD public evidence gathering days: young people’s drug use and naloxone provision

    Register your interest in attending or providing evidence to the ACMD.

  9. Advisory Council on the Misuse of Drugs – Membership

    Details of the council's committees and latest meeting minutes.

  10. Drug-related harms in homeless populations

    ACMD report providing advice to the government on the factors that make the homeless population vulnerable to substance misuse harms and how these can reduced.

  11. Advice on Epidyolex

    Letter to the Home Office regarding the appropriate Schedule for the cannabis-based product for medicinal use, Epidyolex, under the Misuse of Drugs Regulations 2001.

  12. Reducing opioid-related deaths in the UK

    This report by the Advisory Council on the Misuse of Drugs investigates the increase of drug-related deaths in the UK.

  13. Cannabis-based products for medicinal use: assessing the impact

    A framework for the assessment of the impact of rescheduling cannabis-based products for medicinal use (CBPMs).

  14. Advice on the anticonvulsant drugs Pregabalin and Gabapentin

    The chair of the Advisory Council on the Misuse of Drugs writes to Karen Bradley about Pregabalin and Gabapentin.

  15. Misuse of fentanyl and fentanyl analogues

    This report advises government on the number and nature of known fentanyl analogues, risk factors, pharmacology, toxic effects and misuse and associated harms.

  16. ACMD advice on independent prescribing by paramedics

    Letter from Advisory Council on the Misuse of Drugs (ACMD) to ministers, providing advice on independent prescribing of controlled drugs by paramedics.

  17. Appendix One: Forensic Science Service – Methylamphetamine

    Forensic Science Service report Methylamphetamine chemistry, seizure statistics, analysis, synthetic routes and history of illicit manufacture...

  18. Advice on scheduling of cannabis-derived medicinal products

    Advice from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the scheduling of cannabis-derived medicinal products.

  19. Psychoactive Substances Bill: evaluation review

    An evaluation review of the Psychoactive Substances Bill by the Advisory Council on the Misuse of Drugs (ACMD).

  20. ACMD open meeting registration form

    Complete this form to attend the open meeting of the Advisory Council on the Misuse of Drugs in London.